China Shineway Pharmaceutical Group Limited (2877.HK)
HKD 8.7
(-0.57%)
HKD 8.7
(-0.57%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 355 Thousand CNY | -61.07% |
| 2022 | 912 Thousand CNY | -87.55% |
| 2021 | 7.32 Million CNY | -51.26% |
| 2020 | 15.02 Million CNY | 910.63% |
| 2019 | 1.48 Million CNY | 0.0% |
| 2018 | - CNY | 0.0% |
| 2017 | - CNY | 0.0% |
| 2016 | - CNY | 0.0% |
| 2015 | - CNY | 0.0% |
| 2014 | - CNY | 0.0% |
| 2013 | - CNY | 0.0% |
| 2012 | - CNY | 0.0% |
| 2011 | - CNY | 0.0% |
| 2010 | - CNY | 0.0% |
| 2009 | - CNY | 0.0% |
| 2008 | - CNY | 0.0% |
| 2007 | - CNY | 0.0% |
| 2006 | - CNY | 0.0% |
| 2005 | - CNY | 0.0% |
| 2004 | - CNY | 0.0% |
| 2003 | - CNY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 Q4 | 355 Thousand CNY | 0.0% |
| 2023 Q2 | 660 Thousand CNY | 0.0% |
| 2023 FY | 355 Thousand CNY | -61.07% |
| 2022 FY | 912 Thousand CNY | -87.55% |
| 2022 Q2 | 3.82 Million CNY | 0.0% |
| 2022 Q4 | 912 Thousand CNY | 0.0% |
| 2021 Q2 | 10.98 Million CNY | 0.0% |
| 2021 FY | 7.32 Million CNY | -51.26% |
| 2021 Q4 | 7.32 Million CNY | 0.0% |
| 2020 FY | 15.02 Million CNY | 910.63% |
| 2020 Q4 | 15.02 Million CNY | 0.0% |
| 2020 Q2 | 1.03 Million CNY | 0.0% |
| 2019 FY | 1.48 Million CNY | 0.0% |
| 2019 Q2 | 1.9 Million CNY | 0.0% |
| 2019 Q4 | 1.48 Million CNY | 0.0% |
| 2018 Q4 | - CNY | 0.0% |
| 2018 FY | - CNY | 0.0% |
| 2018 Q2 | - CNY | 0.0% |
| 2017 Q4 | - CNY | 0.0% |
| 2017 Q2 | - CNY | 0.0% |
| 2017 FY | - CNY | 0.0% |
| 2016 FY | - CNY | 0.0% |
| 2016 Q4 | - CNY | 0.0% |
| 2016 Q2 | - CNY | 0.0% |
| 2015 FY | - CNY | 0.0% |
| 2015 Q4 | - CNY | 0.0% |
| 2015 Q2 | - CNY | 0.0% |
| 2014 Q4 | - CNY | 0.0% |
| 2014 FY | - CNY | 0.0% |
| 2014 Q2 | - CNY | 0.0% |
| 2013 Q2 | - CNY | 0.0% |
| 2013 FY | - CNY | 0.0% |
| 2013 Q4 | - CNY | 0.0% |
| 2012 Q4 | - CNY | 0.0% |
| 2012 FY | - CNY | 0.0% |
| 2012 Q2 | - CNY | 0.0% |
| 2011 Q2 | - CNY | 0.0% |
| 2011 Q4 | - CNY | 0.0% |
| 2011 FY | - CNY | 0.0% |
| 2010 Q4 | - CNY | 0.0% |
| 2010 FY | - CNY | 0.0% |
| 2010 Q2 | - CNY | 0.0% |
| 2009 FY | - CNY | 0.0% |
| 2009 Q4 | - CNY | 0.0% |
| 2008 FY | - CNY | 0.0% |
| 2007 FY | - CNY | 0.0% |
| 2006 FY | - CNY | 0.0% |
| 2005 FY | - CNY | 0.0% |
| 2004 FY | - CNY | 0.0% |
| 2003 FY | - CNY | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Pak Fah Yeow International Limited | 2.07 Million HKD | 82.875% |
| Grand Pharmaceutical Group Limited | 990.02 Million HKD | 99.964% |
| Extrawell Pharmaceutical Holdings Limited | 117.12 Million HKD | 99.697% |
| Wai Yuen Tong Medicine Holdings Limited | 276.2 Million HKD | 99.871% |
| Qianhai Health Holdings Limited | - HKD | -Infinity% |
| Lee's Pharmaceutical Holdings Limited | 70.63 Million HKD | 99.497% |
| Essex Bio-Technology Limited | 36.05 Million HKD | 99.015% |
| Tongfang Kontafarma Holdings Limited | 12.8 Million HKD | 97.227% |
| PuraPharm Corporation Limited | 81.09 Million HKD | 99.562% |
| SSY Group Limited | 1.94 Billion HKD | 99.982% |
| JBM (Healthcare) Limited | 43.8 Million HKD | 99.189% |
| Jacobson Pharma Corporation Limited | 592.2 Million HKD | 99.94% |
| China Resources Pharmaceutical Group Limited | 16.61 Billion HKD | 99.998% |